These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11281308)

  • 21. Renal dysfunction is the most important predictor of the extent and severity of coronary artery disease in patients with diabetes mellitus.
    Abaci A; Sen N; Yazici H; Tulmac M; Türkoglu S; Tavil Y; Yalcin R
    Coron Artery Dis; 2007 Sep; 18(6):463-9. PubMed ID: 17700218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease.
    Hearn JA; DeMaio SJ; Roubin GS; Hammarstrom M; Sgoutas D
    Am J Cardiol; 1990 Nov; 66(17):1176-80. PubMed ID: 2146869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women.
    Sposito AC; Mansur AP; Maranhão RC; Martinez TR; Aldrighi JM; Ramires JA
    Maturitas; 2001 Sep; 39(3):203-8. PubMed ID: 11574179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between severity of coronary artery athesclerosis and duration and severity of diabetes mellitus in type 2 diabetic patients.
    Uddin SN; Siddiqui NI; Begum F; Malik F; Rahman S
    Mymensingh Med J; 2003 Jul; 12(2):85-8. PubMed ID: 12894038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation.
    Chen J; Zhang Y; Liu J; Chen MH; Guo YL; Zhu CG; Xu RX; Dong Q; Li JJ
    Diab Vasc Dis Res; 2015 Jul; 12(4):258-64. PubMed ID: 25861813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
    Vakkilainen J; Steiner G; Ansquer JC; Aubin F; Rattier S; Foucher C; Hamsten A; Taskinen MR;
    Circulation; 2003 Apr; 107(13):1733-7. PubMed ID: 12665498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.
    Rönnemaa T; Laakso M; Kallio V; Pyörälä K; Marniemi J; Puukka P
    Am J Epidemiol; 1989 Oct; 130(4):632-45. PubMed ID: 2773912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery disease among asymptomatic diabetic and nondiabetic patients undergoing coronary computed tomography angiography.
    Zeina AR; Odeh M; Rosenschein U; Zaid G; Barmeir E
    Coron Artery Dis; 2008 Feb; 19(1):37-41. PubMed ID: 18281814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
    Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
    Circulation; 1990 Jul; 82(1):27-36. PubMed ID: 2194696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart disease.
    Lipinska I; Gurewich V; Meriam CM; Kosowsky BD; Ramaswamy K; Philbin E; Losordo D
    Artery; 1987; 15(1):44-60. PubMed ID: 3435252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular risk factors correlate to the extent as well as the severity of coronary atherosclerosis.
    Wilson SH; Celermajer DS; Nakagomi A; Wyndham RN; Janu MR; Ben Freedman S
    Coron Artery Dis; 1999 Oct; 10(7):449-53. PubMed ID: 10562911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of central fat distribution in coronary artery disease in obesity: comparison of nondiabetic obese, diabetic obese, and normal weight subjects.
    Morricone L; Ferrari M; Enrini R; Inglese L; Giardini D; Garancini P; Caviezel F
    Int J Obes Relat Metab Disord; 1999 Nov; 23(11):1129-35. PubMed ID: 10578202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study.
    Verdoia M; Barbieri L; Schaffer A; Cassetti E; Nardin M; Bellomo G; Aimaretti G; Marino P; Sinigaglia F; De Luca G;
    Metabolism; 2014 May; 63(5):640-6. PubMed ID: 24606806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.